Skip to Main Content

Paper Details

Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
Ann Oncol
3
2023
ACCENT, BRAF, BRAF V600E, BRAF V600E mutation, BRAF mutations, CC, DWT, KRAS, KRAS exon 2, KRAS exon 2 mutants, KRAS exon 2 mutations, MSI, MSS, TTR, colon cancer, microsatellite, microsatellite stable, patient, patients, stage III, tumors
Author NameAffiliation
Steven R AlbertsMayo Clinic
Thomas J GeorgeUniversity of Florida and the University of Florida Health Cancer Center
Pierre Laurent-PuigInstitut du cancer Paris CARPEM, Universite Paris Cite, Sorbonne Universite, Inserm, Universite de Paris Cite
Qian ShiMayo Clinic
  • 1 - 4

Datasets

Release 1.2